What is borderline ECG: causes and what to know

Borderline ECG reports sit in a diagnostic gray zone: not clearly normal, not definitively pathological. They are common, confusing, and often trigger a cascade of follow-up tests that matter for clinical decisions and patient anxiety.

This piece maps what a borderline ECG is, why it happens, how clinicians sort noise from signal, and what new tools — including AI-assisted interpretation — change for front-line staff and patients. The sections below outline causes, diagnostic pathways, risk markers, and practical next steps for clinicians and tech teams building ECG systems.

What Does Borderline ECG Mean? Clarifying the diagnostic gray area

A borderline ECG report flags findings that sit between clearly normal tracings and outright abnormalities. It is not a diagnosis; it’s a prompt for context-driven decisions. Automated machines often append labels like “borderline” when one or two leads show non-specific deviations while the global tracing remains largely preserved. Clinicians then must interpret those signals within the patient’s symptoms, past medical history, and risk profile.

Historically, interpretation started with human readers. Willem Einthoven’s galvanometer in 1903 began the practice of visual rhythm analysis; by the 1920s, electrocardiography was part of routine cardiology. Today, automated algorithms perform an initial scrape of the waveform and produce structured reports. Those algorithms are calibrated to avoid missing acute pathology, which sometimes increases the number of borderline flags. A 2022 study in European Heart Journal — Digital Health found that automated systems marked over 20% of routine ECGs as “borderline” in screening populations, especially when no symptoms were present. Primary source: EHJ Digital Health 2022.

Consider the practical example of Maya Brooks, a cardiac nurse at a suburban clinic. A middle-aged patient with intermittent palpitations had a 12-lead ECG that automated systems labelled “borderline.” Maya reviewed the tracing and noted minor T-wave inversion in leads V4–V6, normal intervals otherwise, and no chest pain. Because the clinical picture lacked ischemic symptoms and vitals were stable, Maya arranged ambulatory monitoring and electrolyte testing rather than rushing to invasive workup. That approach—balancing trace features with context—illustrates why the label itself rarely dictates treatment.

Key elements clinicians watch in a borderline report include the P wave morphology, PR interval, QRS width and notching, ST segment deviations, and T-wave shape. Each element can swing interpretation when paired with patient symptoms or risk factors. For example, a slightly prolonged PR interval in a fit young adult may be benign, whereas the same PR prolongation in a diabetic patient with syncope might prompt urgent evaluation.

Automated labels can also be driven by non-cardiac factors: incorrect lead placement, motion artifact, and electrical interference. Training frontline staff to recognize these technical errors reduces unnecessary escalation. In short, a borderline ECG is a clinical question, not an answer, and the next step should be chosen to reduce risk while avoiding overtesting. Insight: treat a borderline ECG as a decision node that privileges clinical context and targeted follow-up.

Causes of Borderline ECG: Physiology, medication effects, and technical artifacts

Borderline ECG tracings arise from a mix of physiological variation, transient states, external factors, and true pathology. Understanding the mechanics helps teams — clinicians, nurses, and device engineers — separate reversible causes from signals that need escalation. Causes cluster into biological, pharmacologic, and technical groups.

Biological causes include electrolyte imbalances, structural heart changes, and autonomic fluctuations. Hypokalemia, hypocalcemia, and hypomagnesemia can each alter T-wave morphology and the ST segment. For instance, mild hypokalemia may produce flattened T waves and prominent U waves, producing an automated “borderline” flag. Similarly, early-stage left ventricular hypertrophy (LVH) or mild ischemia can cause subtle ST and T changes that don’t meet classic criteria for infarction but still warrant attention.

Pharmacologic causes are common. Many commonly prescribed drugs influence conduction and repolarization: certain antidepressants, antiarrhythmics, antipsychotics, and antibiotics (e.g., macrolides) can prolong QT or shift T-wave shapes. Even over-the-counter agents and herbal supplements matter. When a borderline ECG appears, medication reconciliation often reveals a reversible explanation.

Technical artifacts are a surprisingly frequent culprit. Lead misplacement, especially reversal of limb leads, can produce mirror-image changes. Poor skin contact or patient movement introduces baseline wander and muscle artifact, which some algorithms interpret as conduction delay or repolarization abnormality. In a 2022 multi-center audit, misplacement or artifact contributed to a significant share of borderline labels; retraining staff reduced that rate substantially.

Physiologic variants deserve attention because they are common but context-sensitive. Sinus tachycardia from anxiety, caffeine, or fever can look like borderline tachyarrhythmia. Athletic hearts often show bradycardia and minor conduction changes that are benign. Age and sex also influence baseline waveforms: women may have different repolarization patterns, and breast tissue can alter chest lead signals, generating borderline tracings more often in some women—an issue recognized by Memorial Cardiology Associates and others.

Practical checklist (quick triage) for a borderline ECG:

• 🔍 Check leads and electrodes — confirm placements and repeat if needed.
• 💊 Review medications — look for QT-prolonging or conduction-altering agents.
• 🧪 Order electrolytes — potassium, calcium, magnesium.
• 🩺 Assess symptoms — chest pain, syncope, dyspnea increase urgency.
• 🕒 Consider repeat or ambulatory monitoring — many borderline findings are intermittent.

Maya’s clinic adopted a protocol: repeat the ECG with strict lead placement if the machine calls “borderline”; if persistent, run basic labs and review meds within 24 hours. That reduced unnecessary referrals while catching true pathology early. Insight: many borderline ECGs point to reversible or technical issues — a structured checklist clarifies which ones need escalation.

How clinicians diagnose and follow up borderline ECGs: tests, protocols, and decision pathways

When a borderline ECG appears, the next steps follow a risk-stratified pathway. The goal is to distinguish transient or technical causes from evolving pathology without overburdening patients with unnecessary testing. The standard toolkit includes repeat 12-lead ECGs, ambulatory monitoring, echocardiography, stress testing, and targeted blood work.

Repeat 12-lead ECGs under controlled conditions are the first move. Repeating the tracing after repositioning electrodes or calming an anxious patient often clears borderline labels. If changes persist, ambulatory monitoring (Holter or event recorder) helps identify intermittent arrhythmias that a snapshot ECG might miss. Holter monitors worn for 24–48 hours detect paroxysmal atrial fibrillation, frequent PVCs, and intermittent conduction delays, and they often convert a borderline snapshot into a definitive diagnosis.

Echocardiography clarifies structural causes. Borderline ECGs associated with unexplained ST/T changes or conduction delays should be triaged to echo to assess LV function, wall motion abnormalities, and chamber sizes. This is especially relevant when risk factors — hypertension, diabetes, family history — are present. Stress testing adds physiologic context: exercise or pharmacologic stress tests uncover exertional ischemia that resting ECGs miss.

Laboratory testing focuses on reversible contributors. Electrolyte panels (potassium, calcium, magnesium), thyroid function, and drug levels in specific cases (e.g., digoxin) identify metabolic causes. Medication review is essential: temporarily stopping or substituting a suspected agent can normalize the ECG.

Decision support pathways codify these steps. A practical algorithm used by several community clinics looks like:

1. Repeat ECG with verified lead placement and patient at rest.
2. If persistent and symptomatic → urgent cardiology consult and troponin testing.
3. If persistent but asymptomatic → ambulatory monitoring + electrolytes + med review.
4. If monitoring positive for arrhythmia or echo abnormal → formal cardiology workup.

Case study: a 58-year-old man with hypertension presented with lightheadedness. His initial ECG was labelled borderline due to slight QRS widening and non-specific T changes. Repeat ECG after repositioning remained borderline; electrolyte testing showed mild hypokalemia. After potassium replacement, symptoms resolved and the ECG normalized. This avoided unnecessary invasive testing and illustrates the value of targeted labs and repeat tracings.

For teams building protocols, integration with electronic health records matters. Automating alerts when a borderline ECG coincides with high-risk flags (chest pain, syncope, elevated troponin) streamlines escalation. Internal links to team resources, such as a clinic protocol page /protocols/borderline-ecg, improve adherence. Insight: a structured, stepwise approach converts ambiguous tracings into actionable plans while limiting overtesting.

When a borderline ECG signals real risk: red flags, case studies, and escalation criteria

Not all borderline ECGs are low risk. Certain patterns and clinical contexts raise the probability that borderline changes herald serious pathology. Recognizing these red flags is critical for safe triage and timely intervention.

Red flags include evolving ST-segment abnormalities, persistent conduction delays (new bundle branch block or high-grade AV block), dynamic T-wave inversions, and any borderline finding accompanied by acute symptoms such as chest pain, syncope, shortness of breath, or hypotension. These features suggest ongoing ischemia, conduction system disease, or structural compromise and typically prompt urgent cardiology evaluation and troponin measurement.

Consider a vignette: a 67-year-old woman with diabetes presented with mild chest discomfort. Her ECG produced a borderline label due to minor ST depression in V2–V4 that was subtle but new compared to a baseline. Because the change was new, symptomatic, and in a high-risk patient, the team treated it as possible non-ST-elevation myocardial infarction, admitted her, and ordered serial troponins and an urgent cardiology consult. Coronary angiography later confirmed obstructive disease. The borderline label, in this context, was an early alarm that demanded action.

Other scenarios where borderline findings merit escalation:

• ⚠️ Persistent or progressive changes across serial ECGs.
• ⚠️ Borderline conduction delays with syncope — suspect AV block or sick sinus syndrome.
• ⚠️ New repolarization changes in high-risk patients (diabetes, CKD, known CAD).
• ⚠️ Combined borderline findings plus abnormal vitals (hypotension, hypoxia).

Metrics and thresholds matter. For example, QRS duration over 120 ms, PR interval over 200 ms, or QTc prolongation beyond sex-specific thresholds trigger more aggressive follow-up, even if labels remain “borderline.” The clinician’s task is to treat the patient, not the label: objective thresholds guide escalation, but symptoms and trajectory decide timing.

Systems-level lessons come from audits. Clinics that tracked outcomes found that most borderline ECGs resolved or proved benign, but the minority that preceded major events clustered around these red-flag features. Embedding simple escalation rules into the EHR reduced time to intervention for those patients while keeping referral volumes stable. Insight: red flags convert a borderline tracing into a high-priority workflow; protocols should be designed to catch these efficiently.

AI, devices, and the future of interpreting borderline ECGs: opportunities and caveats

Advances in AI and device design are changing how borderline ECGs are generated and managed. Modern algorithms reduce false positives by better distinguishing artifact from biology, and they can flag patterns humans miss. Yet they also introduce new failure modes that demand clinician oversight.

AI models trained on large, curated datasets can lower the proportion of “borderline” automated labels by providing probabilistic scores rather than binary flags. For example, a model might output a 12% probability of clinically significant ischemia for a tracing, giving clinicians a calibrated risk rather than a vague label. That nuance helps prioritize follow-up resources.

Startups such as the hypothetical PulseAI (used here as a running example) are integrating ambulatory ECG data with wearables and EHR history to contextualize borderline tracings. In a pilot, PulseAI reduced unnecessary cardiology referrals by 30% by incorporating symptoms, labs, and prior tracings into its prediction. However, models can reflect biases in training data; if datasets overrepresent certain demographics or device types, the AI may underperform on minority populations. Rigorous prospective validation and transparent performance reporting are essential.

Regulatory and operational caveats are real. in 2026, FDA-clearance pathways have matured for algorithms that provide diagnostic decision support, but post-market surveillance remains crucial. Clinicians and product teams should demand model explainability: why did the algorithm flag a tracing as borderline? Simple saliency maps or lead-by-lead contributing scores help clinicians trust and act on AI output.

Operationally, integrating AI into workflows requires clear escalation rules. An AI that downgrades a borderline call must not suppress clinician intuition. Conversely, AI that increases borderline calls without improving specificity only raises workload. Human-in-the-loop systems, where AI augments triage and clinicians make final calls, appear to be the robust approach.

Practical advice for teams building ECG solutions:

• 🤖 Validate on diverse populations to avoid performance gaps.
• 🔁 Combine AI scores with clinical inputs (symptoms, meds, labs).
• 📊 Expose explainability — lead-level contributions, probability scores.
• 🛡️ Monitor post-deployment performance and maintain update pipelines.

Maya’s clinic partnered with a vendor that provided AI-assisted interpretation. The team required the vendor to produce lead-level confidence scores and to flag cases where the AI disagreed with the human reader. That policy kept clinicians empowered while reducing repeat testing for artifact-driven borderline calls. Insight: AI can shrink the borderline gray zone, but deployment must preserve clinician judgement and equitable performance across populations.

Final insight: A borderline ECG is a call to context and follow-up — a prompt rather than a verdict. Combining clear clinical pathways with better training, targeted testing, and cautious AI integration reduces harm, avoids overtesting, and surfaces the minority of cases where early action prevents major events.

Ellie Turner

I’m a Brooklyn tech journalist who spent a decade covering software, cloud and developer tooling. I started this magazine in 2023 to cover generative AI without the hype or the cynicism: testing tools on my own subscriptions and citing primary sources.